Psoriasis Treatment Market 2019 Size, Share, Growth | Global Industry Research Report, 2026
SKU ID : FBUIN-14602546 | Publishing Date : 01-Jun-2019
Detailed TOC of Psoriasis Treatment Market 2019 Size, Share, Growth | Global Industry Research Report, 2026
TABLE OF CONTENT:1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Psoriasis and Psoriatic Arthritis for Key Countries/Region
4.2. Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
4.3. Pipeline Analysis for Key Companies
4.4. Regulatory Framework by Key Countries
4.5. Global Reimbursement Scenario
5. Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Drug Class
5.2.1. TNF Inhibitors
5.2.2. Interleukins
5.2.3. Others
5.3. Market Analysis, Insights and Forecast – By Type
5.3.1. Plaque Psoriasis
5.3.2. Psoriatic Arthritis
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Route of Administration
5.4.1. Oral
5.4.2. Parenteral
5.4.3. Topical
5.5. Market Analysis, Insights and Forecast – By Distribution Channel
5.5.1. Hospital Pharmacies
5.5.2. Retail Pharmacies
5.5.3. Online pharmacies
5.6. Market Analysis, Insights and Forecast – By Region
5.6.1. North America
5.6.2. Europe
5.6.3. Asia pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
6. North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Drug Class
6.2.1. TNF Inhibitors
6.2.2. Interleukins
6.2.3. Others
6.3. Market Analysis – By Type
6.3.1. Plaque Psoriasis
6.3.2. Psoriatic Arthritis
6.3.3. Others
6.4. Market Analysis – By Route of Administration
6.4.1. Oral
6.4.2. Parenteral
6.4.3. Topical
6.5. Market Analysis – By Distribution Channel
6.5.1. Hospital Pharmacies
6.5.2. Retail Pharmacies
6.5.3. Online pharmacies
6.6. Market Analysis – By Country/Sub-region
6.6.1. U.S.
6.6.2. Canada
7. Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Drug Class
7.2.1. TNF Inhibitors
7.2.2. Interleukins
7.2.3. Others
7.3. Market Analysis – By Type
7.3.1. Plaque Psoriasis
7.3.2. Psoriatic Arthritis
7.3.3. Others
7.4. Market Analysis – By Route of Administration
7.4.1. Oral
7.4.2. Parenteral
7.4.3. Topical
7.5. Market Analysis – By Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2. Retail Pharmacies
7.5.3. Online pharmacies
7.6. Market Analysis – By Country/Sub-region
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. Australia
7.6.5. Southeast Asia
7.6.6. Rest of Asia Pacific
8. Europe Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Drug Class
8.2.1. TNF Inhibitors
8.2.2. Interleukins
8.2.3. Others
8.3. Market Analysis – By Type
8.3.1. Plaque Psoriasis
8.3.2. Psoriatic Arthritis
8.3.3. Others
8.4. Market Analysis – By Route of Administration
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
8.5. Market Analysis – By Distribution Channel
8.5.1. Hospital Pharmacies
8.5.2. Retail Pharmacies
8.5.3. Online pharmacies
8.6. Market Analysis – By Country/Sub-region
8.6.1. U.K.
8.6.2. Germany
8.6.3. France
8.6.4. Spain
8.6.5. Italy
8.6.6. Scandinavia
8.6.7. Rest of Europe
9. Latin America Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis – By Drug Class
9.2.1. TNF Inhibitors
9.2.2. Interleukins
9.2.3. Others
9.3. Market Analysis – By Type
9.3.1. Plaque Psoriasis
9.3.2. Psoriatic Arthritis
9.3.3. Others
9.4. Market Analysis – By Route of Administration
9.4.1. Oral
9.4.2. Parenteral
9.4.3. Topical
9.5. Market Analysis – By Distribution Channel
9.5.1. Hospital Pharmacies
9.5.2. Retail Pharmacies
9.5.3. Online pharmacies
9.6. Market Analysis – By Country/Sub-region
9.6.1. Brazil
9.6.2. Mexico
9.6.3. Rest of Latin America
10. Middle East & Africa Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis – By Drug Class
10.2.1. TNF Inhibitors
10.2.2. Interleukins
10.2.3. Others
10.3. Market Analysis – By Type
10.3.1. Plaque Psoriasis
10.3.2. Psoriatic Arthritis
10.3.3. Others
10.4. Market Analysis – By Route of Administration
10.4.1. Oral
10.4.2. Parenteral
10.4.3. Topical
10.5. Market Analysis – By Distribution Channel
10.5.1. Hospital Pharmacies
10.5.2. Retail Pharmacies
10.5.3. Online pharmacies
10.6. Market Analysis – By Country/Sub-region
10.6.1. GCC Countries
10.6.2. South Africa
10.6.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.5.1. AbbVie Inc.
11.5.2. Novartis AG
11.5.3. Johnson & Johnson Services, Inc.
11.5.4. Pfizer Inc.,
11.5.5. LEO Pharma A/S
11.5.6. Merck & Co., Inc.
11.5.7. Amgen Inc.
11.5.8. Eli Lilly and Company
11.5.9. CELGENE CORPORATION
11.5.10. UCB S.A.
11.5.11. Sun Pharmaceutical Industries Ltd.
11.5.12. Other prominent players
12. Strategic Recommendations
Keyplayers in Psoriasis Treatment Market 2019 Size, Share, Growth | Global Industry Research Report, 2026
AbbVie Inc.Novartis AG
Johnson & Johnson Services, Inc.
Pfizer Inc.,
LEO Pharma A/S
Merck & Co., Inc.
Amgen Inc.
Eli Lilly and Company
CELGENE CORPORATION
UCB S.A.
Sun Pharmaceutical Industries Ltd.
Other prominent players